|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (1996)) |
Withdrawn drug? | Yes |
IUPAC Name ![]() |
2-amino-5-oxo-7-(propan-2-yl)-5H-chromeno[2,3-b]pyridine-3-carboxylic acid |
International Nonproprietary Names ![]() |
|
INN number | INN |
5950 | amlexanox |
Synonyms ![]() |
AA-673 | Amlexanox® | Aphthasol® | CHX-3673 |
Comments |
Amlexanox has anti-inflammatory [1], antiallergic and immunomodulatory actions [2]. Proposed to inhibit IKKδ and TBK1, albeit with low potency [5]. |
Database Links ![]() |
|
CAS Registry No. | 68302-57-8 |
ChEMBL Ligand | CHEMBL1096 |
DrugBank Ligand | DB01025 |
GtoPdb PubChem SID | 178103690 |
PubChem CID | 2161 |
RCSB PDB Ligand | ANW |
Search Google for chemical match using the InChIKey | SGRYPYWGNKJSDL-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | SGRYPYWGNKJSDL |
Search PubMed clinical trials | amlexanox |
Search PubMed titles | amlexanox |
Search PubMed titles/abstracts | amlexanox |
Search UniChem for chemical match using the InChIKey | SGRYPYWGNKJSDL-UHFFFAOYSA-N |
Search UniChem for chemicals with the same backbone | SGRYPYWGNKJSDL |
Wikipedia | Amlexanox |
Amlexanox
Cat. No. 4857 |